Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glioblastoma Immune Landscape and the Potential of New Immunotherapies
Thomas Daubon, Audrey Hémadou, Irati Romero‐Garmendia, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Glioblastoma Treatment: State-of-the-Art and Future Perspectives
Alejandro Rodríguez-Camacho, José Guillermo Flores-Vázquez, Júlia Moscardini-Martelli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7207-7207
Open Access | Times Cited: 81
Macrophages in Recurrent Glioblastoma as a Prognostic Factor in the Synergistic System of the Tumor Microenvironment
Nicola Montemurro, Bhavya Pahwa, Anish Tayal, et al.
Neurology International (2023) Vol. 15, Iss. 2, pp. 595-608
Open Access | Times Cited: 42
Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy
Zhiqi Zhang, Xiaoxuan Xu, Jiawei Du, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 34
Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy
Deepak Chandra Joshi, Anurag Sharma, Sonima Prasad, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 24
Cancer cell heterogeneity & plasticity in glioblastoma and brain tumors
Adam Lauko, Alice Lo, Manmeet S. Ahluwalia, et al.
Seminars in Cancer Biology (2021) Vol. 82, pp. 162-175
Open Access | Times Cited: 95
Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
Yang Xun, Hua Yang, Bożena Kamińska, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 85
Advances in immunotherapy for glioblastoma multiforme
Ahmad Bakur Mahmoud, Reham Ajina, Sarah Aref, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 66
The Hallmarks of Glioblastoma: Heterogeneity, Intercellular Crosstalk and Molecular Signature of Invasiveness and Progression
Filippo Torrisi, Cristiana Alberghina, Simona D’Aprile, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 806-806
Open Access | Times Cited: 65
The Promise of Niacin in Neurology
Emily Wuerch, Gloria Roldan Urgoiti, V. Wee Yong
Neurotherapeutics (2023) Vol. 20, Iss. 4, pp. 1037-1054
Open Access | Times Cited: 32
Targeting IGF2BP3 in Cancer
Xin Liu, Jiayu Chen, Wenliang Chen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9423-9423
Open Access | Times Cited: 27
Current approaches in glioblastoma multiforme immunotherapy
Marjan Aghajani, Nazila Jalilzadeh, Ali Aghebati‐Maleki, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 7, pp. 1584-1612
Closed Access | Times Cited: 13
The Role of Immune Checkpoint Molecules on Macrophages in Cancer, Infection, and Autoimmune Pathologies
Victoria C. Brom, C. Burger, Dieter Christian Wirtz, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects
Estela Pineda, Marta Domènech, Ainhoa Hernández, et al.
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 71-86
Open Access | Times Cited: 20
Interaction of tumor-associated microglia/macrophages and cancer stem cells in glioma
Xiangling Zhu, Yilong Fang, Yizhao Chen, et al.
Life Sciences (2023) Vol. 320, pp. 121558-121558
Open Access | Times Cited: 19
A genome-wide in vivo CRISPR screen identifies essential regulators of T cell migration to the CNS in a multiple sclerosis model
Arek Kendirli, Clara de la Rosa, Katrin F. Lämmle, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 10, pp. 1713-1725
Open Access | Times Cited: 19
EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes
Ranim El Baba, Sébastien Pasquereau, Sandy Haidar Ahmad, et al.
Oncogene (2023) Vol. 42, Iss. 24, pp. 2031-2045
Open Access | Times Cited: 18
CAR-NK cell therapy for glioblastoma: what to do next?
Qi Xiong, Jiao Zhu, Yong Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 18
Generation of glioblastoma in mice engrafted with human cytomegalovirus-infected astrocytes
Joris Guyon, Sandy Haidar Ahmad, Ranim El Baba, et al.
Cancer Gene Therapy (2024)
Open Access | Times Cited: 6
Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era
Augusto Leone, Antonio Colamaria, Nicola Pio Fochi, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1927-1927
Open Access | Times Cited: 25
Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis
Zhe Zhang, Xiaoli Shen, Zilong Tan, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 13
Regulation of MHC I Molecules in Glioblastoma Cells and the Sensitizing of NK Cells
Timo Burster, Fabian Gärtner, Christiane Bulach, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 236-236
Open Access | Times Cited: 28
Syngeneic murine glioblastoma models: reactionary immune changes and immunotherapy intervention outcomes
Vijay Letchuman, Leonel Ampie, Ashish H. Shah, et al.
Neurosurgical FOCUS (2022) Vol. 52, Iss. 2, pp. E5-E5
Open Access | Times Cited: 21
Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions
Jing Zhou, Luohong Li, Minqi Jia, et al.
Cancer Medicine (2022) Vol. 12, Iss. 6, pp. 7207-7221
Open Access | Times Cited: 21
Glioblastoma Microenvironment: From an Inviolable Defense to a Therapeutic Chance
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 19
An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas
Georgios M. Stergiopoulos, Susanna C. Concilio, Evanthia Galanis
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 7, pp. 952-991
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top